Search research articles
Contact Us
Filters
Showing results (801-810 of 839) with videos related to
Page
of 84
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2022
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer
B Ricciuti, J V Alessi, A Elkrief, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Nature Cancer
|
July 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
Ines Mota, Enrico Patrucco, Cristina Mastini, et al.
Journal for Immunotherapy of Cancer
|
February 17, 2022
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations
Alessio Cortellini, Biagio Ricciuti, Victor R Vaz, et al.
Nature Genetics
|
August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao, Claire A Margolis, Natalie I Vokes, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2026
Evolution of oncogene amplification across 86,000 cancer cell genomes
Jake June-Koo Lee, Sohrab Salehi, Matthew A Myers, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 30, 2021
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study
Sheena Bhalla, Ziad Bakouny, Andrew L Schmidt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 6, 2021
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status
Biagio Ricciuti, Kathryn C Arbour, Jessica J Lin, et al.
Cancer Immunology Research
|
April 24, 2020
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors
Sarah Abou Alaiwi, Amin H Nassar, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 2024
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, et al.
Page
of 84
Search research articles
Search
Showing results (801-810 of 839) with videos related to
Sort By:
Page
of 84
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2022
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRAS<sup>G12D</sup>-mutated non-small-cell lung cancer
B Ricciuti, J V Alessi, A Elkrief, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K Hastings, H A Yu, W Wei, et al.
Nature Cancer
|
July 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
Ines Mota, Enrico Patrucco, Cristina Mastini, et al.
Journal for Immunotherapy of Cancer
|
February 17, 2022
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations
Alessio Cortellini, Biagio Ricciuti, Victor R Vaz, et al.
Nature Genetics
|
August 29, 2018
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao, Claire A Margolis, Natalie I Vokes, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2026
Evolution of oncogene amplification across 86,000 cancer cell genomes
Jake June-Koo Lee, Sohrab Salehi, Matthew A Myers, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 30, 2021
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study
Sheena Bhalla, Ziad Bakouny, Andrew L Schmidt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 6, 2021
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status
Biagio Ricciuti, Kathryn C Arbour, Jessica J Lin, et al.
Cancer Immunology Research
|
April 24, 2020
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors
Sarah Abou Alaiwi, Amin H Nassar, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 2024
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, et al.
Page
of 84